Dr. Bin Li 李斌
Chief Physician
Department of Gynecologic Oncology, Cancer Hospital, Chinese Academy of Medical Sciences (National Cancer Center), Beijing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical, radiation, and chemotherapy treatment for cervical, endometrial, and ovarian cancers. Specializes in radical cervical cancer surgery, ovarian cancer cytoreduction, laparoscopic techniques, and nerve-sparing or fertility-preserving procedures.
Dr. Li graduated from Shanghai Medical University in 1993 and earned a doctoral degree in oncology from Peking Union Medical College. A Chief Physician and doctoral supervisor at the Cancer Hospital, Chinese Academy of Medical Sciences, Dr. Li has over 20 years of experience in gynecologic oncology. Dr. Li leads nine research projects, has published over 20 papers, edited one monograph, co-translated six, and received nine awards.
Professional roles
- Youth Committee Member, Gynecologic Oncology Branch, Chinese Medical Association
- Director, Obstetrics and Gynecology Physicians Branch, Beijing Medical Doctor Association
Name order: in Chinese the family name comes first (Li Bin). Papers usually list the name as Bin Li or Li B.
Selected publications
89 papers on PubMed matched by name and affiliation; 19 as first or senior author since 2016. Most recent first- or senior-author papers:
- Int J Womens Health, 2026 (senior author): Limited Survival Benefit of Preoperative Conization Before Radical Surgery in Stage IB Cervical Cancer: An IPTW-Adjusted Retrospective Cohort Study. PubMed 42472258
- Biomed Opt Express, 2026 (senior author): Enhanced terahertz near-field nanoscopic imaging for label-free assessment of ovarian cancer cells: a preliminary study. PubMed 42111018
- Adv Mater, 2026 (senior author): Polymer-PARPi Conjugates Delivering USP1i for Maximizing Synthetic Lethality to Stimulate STING Pathway in High-Grade Serous Ovarian Cancer. PubMed 40970784
- Nat Genet, 2025 (senior author): Single-cell multi-omic and spatial profiling of esophageal squamous cell carcinoma reveals the immunosuppressive role of GPR116(+) pericytes in cancer metastasis. PubMed 41073785
- Chin Med J (Engl), 2025 (senior author): Value of adjuvant chemotherapy in IB-lIA cervical adenocarcinoma: A multicenter retrospective study. PubMed 40736215
- Transl Oncol, 2025 (senior author): Enhancing ovarian cancer prognosis with an artificial intelligence-derived model: Multi-omics integration and therapeutic implications. PubMed 40580871
- Eur J Surg Oncol, 2025 (senior author): Predictive factors of sentinel lymph node mapping failure in cervical cancer: A systematic review and meta-analysis. PubMed 40555135
- Front Immunol, 2025 (senior author): Analysis of m7G-related signatures in the tumor immune microenvironment and identification of clinical prognostic regulators in ovarian cancer. PubMed 40895564
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion